|
|||
Names | |||
---|---|---|---|
Preferred IUPAC name
(4-Hydroxy-3-methoxyphenyl)acetic acid
|
|||
Other names
2-(4-Hydroxy-3-methoxyphenyl)acetic acid; 3-Methoxy-4-hydroxyphenylacetic acid; 4-Hydroxy-3-methoxy-benzeneacetic acid
|
|||
Identifiers | |||
3D model (Jmol)
|
|||
ChEBI | |||
ChemSpider | |||
ECHA InfoCard | 100.005.616 | ||
KEGG | |||
MeSH | Homovanillic+acid | ||
PubChem CID
|
|||
|
|||
|
|||
Properties | |||
C9H10O4 | |||
Molar mass | 182.18 g·mol−1 | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|||
what is ?) | (|||
Infobox references | |||
Homovanillic acid (HVA) is a major catecholamine metabolite and is produced by the consecutive action of monoamine oxidase and catechol-O-methyl transferase on dopamine. It is used as a reagent to detect oxidative enzymes, and is associated with dopamine levels in the brain.
In psychiatry and neuroscience, brain and cerebrospinal fluid levels of HVA are measured as a marker of metabolic stress caused by 2-deoxy-D-glucose. HVA presence supports a diagnosis of neuroblastoma and malignant pheochromocytoma.
Fasting plasma levels of HVA are known to be higher in females than in males. This does not seem to be influenced by adult hormonal changes, as the pattern is retained in the elderly and post-menopausal as well as transgender people according to their genetic sex, both before and during cross-sex hormone administration. Differences in HVA have also been correlated to tobacco usage, with smokers showing significantly lower amounts of plasma HVA.